Advances in gene therapy for high-grade glioma: a review of the clinical evidence-Reference-Cited by-同舟云学术

Advances in gene therapy for high-grade glioma: a review of the clinical evidence

Published:2024-08 Issue:9 Volume:24 Page:879-895
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Goldman Matthew J.¹^ORCID,Baskin Alexandra M.¹²³,Sharpe Martyn A.¹²³,Baskin David S.¹²³⁴⁵

Affiliation:

1. Department of Neurosurgery, Houston Methodist Hospital, Houston, TX, USA

2. Kenneth R. Peak Center for Brain and Pituitary Tumor Treatment and Research, Houston Methodist Hospital, Houston, TX, USA

3. Houston Methodist Academic Institute, Houston, TX, USA

4. Department of Neurosurgery, Weill Cornell Medical College, New York, NY, USA

5. Department of Medicine, Texas A & M Medical School

Funder

Donna and Kenneth Peak and the Kenneth R. Peak Foundation

John S. Dunn Foundation

Green Fund

Pauline Sterne Wolff Memorial Foundation

Kelly Kicking Cancer Foundation

Methodist Hospital Foundation

Veralan Foundation

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2024.2376847

Reference86 articles.

1. Emerging therapies for glioblastoma: current state and future directions

2. Cancer of the brain and other nervous system – cancer stat facts. SEER. [cited 2024 Mar 3]. Available from: https://seer.cancer.gov/statfacts/html/brain.html

3. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

4. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

5. NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality